In severe COVID-19 patients, mucosal non-neutralizing SARS-CoV-2 IgA persisted after viral clearance in the lung, suggesting that IgA may exert harmful functions beside protective neutralization at mucosal level (82). This evidence concerns the gene CD79A and COVID-19.